Tokyo Tape
Sign in
← Sumitomo Chemical

Quarterly report · Q2

4005.TEDINET S100PHEX
Period2022-04-01 → 2022-09-30
Filed2022-11-08
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 59
MetricValuePeriodScopeSource row
Revenue¥1.53T2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥754.4bn2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥2.77T2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.33T2021-04-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥686.2bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income¥60.6bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income−¥5.7bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥144.3bn2021-04-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥85.9bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥126.8bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥13.1bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥251.1bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥146.8bn2021-04-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥90.1bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥81.1bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥11.1bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥162.1bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥88.9bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥53.2bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥73.1bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income−¥12.0bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥186.4bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥107.8bn2021-04-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥68.9bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥4.68Tat 2022-09-30Cons.Assets IFRS
Total assets¥4.31Tat 2022-03-31Cons.Assets IFRS
Total assets¥4.08Tat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥2.79Tat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥2.61Tat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥1.89Tat 2022-09-30Cons.Equity IFRS
Net assets / equity¥1.70Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥1.55Tat 2021-09-30Cons.Equity IFRS
Net assets / equity¥1.48Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥1.38Tat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.22Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.08Tat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥486.0bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥365.4bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥346.8bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥360.9bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥83.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥171.7bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥77.2bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥15.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥115.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥65.2bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥24.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥81.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥27.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥49.582022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥6.772022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥99.162021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥54.362021-04-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥32.552021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥49.572022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥6.772022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio29.5%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio28.3%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio26.5%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 124
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥79.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-07-01 → 2022-09-30¥47.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥37.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-07-01 → 2022-09-30¥23.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥42.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-07-01 → 2022-09-30¥24.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-07-01 → 2022-09-30−¥708m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥57.6bn
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-09-30−¥32.7bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥57.6bn
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-09-30−¥32.7bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥11.6bn
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-09-30−¥4.1bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue2022-04-01 → 2022-09-30¥183.7bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue2022-07-01 → 2022-09-30¥92.4bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2022-04-01 → 2022-09-30¥173.5bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2022-07-01 → 2022-09-30¥87.1bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥10.1bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥5.3bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2022-04-01 → 2022-09-30¥13.4bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2022-07-01 → 2022-09-30¥6.8bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2022-04-01 → 2022-09-30¥470.4bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2022-07-01 → 2022-09-30¥230.3bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2022-04-01 → 2022-09-30¥467.3bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2022-07-01 → 2022-09-30¥228.7bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥3.1bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥1.6bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2022-04-01 → 2022-09-30¥23.3bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2022-07-01 → 2022-09-30¥13.3bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2022-04-01 → 2022-09-30¥295.9bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2022-07-01 → 2022-09-30¥142.4bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2022-04-01 → 2022-09-30¥293.9bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2022-07-01 → 2022-09-30¥141.3bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥2.0bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥1.1bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2022-04-01 → 2022-09-30¥36.3bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2022-07-01 → 2022-09-30¥14.4bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue2022-04-01 → 2022-09-30¥222.4bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue2022-07-01 → 2022-09-30¥107.7bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2022-04-01 → 2022-09-30¥222.2bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2022-07-01 → 2022-09-30¥107.5bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥234m
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥118m
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2022-04-01 → 2022-09-30¥26.4bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2022-07-01 → 2022-09-30¥10.7bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥334.5bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue2022-07-01 → 2022-09-30¥166.7bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥334.4bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue external2022-07-01 → 2022-09-30¥166.7bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥7m
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥1m
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥25.2bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentsegment profit2022-07-01 → 2022-09-30¥11.1bn
—segment totalrevenue2022-04-01 → 2022-09-30¥1.51T
—segment totalrevenue2022-07-01 → 2022-09-30¥739.5bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥1.49T
—segment totalrevenue external2022-07-01 → 2022-09-30¥731.4bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥15.5bn
—segment totalrevenue intersegment2022-07-01 → 2022-09-30¥8.1bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥124.7bn
—segment totalsegment profit2022-07-01 → 2022-09-30¥56.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-09-30¥59.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-07-01 → 2021-09-30¥31.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-09-30¥30.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-07-01 → 2021-09-30¥17.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-09-30¥29.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-07-01 → 2021-09-30¥14.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30¥6.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-07-01 → 2021-09-30¥4.0bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥41.3bn
Reconciling Itemsreconcilingrevenue2021-07-01 → 2021-09-30−¥20.3bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥41.3bn
Reconciling Itemsreconcilingrevenue intersegment2021-07-01 → 2021-09-30−¥20.3bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥10.4bn
Reconciling Itemsreconcilingsegment profit2021-07-01 → 2021-09-30−¥5.4bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue2021-04-01 → 2021-09-30¥154.5bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue2021-07-01 → 2021-09-30¥77.1bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2021-04-01 → 2021-09-30¥148.5bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2021-07-01 → 2021-09-30¥74.1bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥6.0bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥3.0bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2021-04-01 → 2021-09-30¥12.6bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2021-07-01 → 2021-09-30¥5.9bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2021-04-01 → 2021-09-30¥402.1bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2021-07-01 → 2021-09-30¥201.4bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2021-04-01 → 2021-09-30¥399.5bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2021-07-01 → 2021-09-30¥200.0bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥2.6bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥1.4bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2021-04-01 → 2021-09-30¥42.0bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2021-07-01 → 2021-09-30¥18.2bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2021-04-01 → 2021-09-30¥212.8bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2021-07-01 → 2021-09-30¥107.3bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2021-04-01 → 2021-09-30¥209.4bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2021-07-01 → 2021-09-30¥106.4bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥3.3bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥955m
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2021-04-01 → 2021-09-30¥18.5bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2021-07-01 → 2021-09-30¥8.2bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue2021-04-01 → 2021-09-30¥227.9bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue2021-07-01 → 2021-09-30¥118.5bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2021-04-01 → 2021-09-30¥227.7bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2021-07-01 → 2021-09-30¥118.4bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥226m
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥116m
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2021-04-01 → 2021-09-30¥29.5bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2021-07-01 → 2021-09-30¥16.0bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue2021-04-01 → 2021-09-30¥309.6bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue2021-07-01 → 2021-09-30¥170.4bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue external2021-04-01 → 2021-09-30¥309.6bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue external2021-07-01 → 2021-09-30¥170.4bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥9m
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥7m
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentsegment profit2021-04-01 → 2021-09-30¥50.0bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentsegment profit2021-07-01 → 2021-09-30¥40.3bn
—segment totalrevenue2021-04-01 → 2021-09-30¥1.31T
—segment totalrevenue2021-07-01 → 2021-09-30¥674.7bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥1.29T
—segment totalrevenue external2021-07-01 → 2021-09-30¥669.2bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥12.2bn
—segment totalrevenue intersegment2021-07-01 → 2021-09-30¥5.5bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥152.6bn
—segment totalsegment profit2021-07-01 → 2021-09-30¥88.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 994
ItemContextValueUnit
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1QuarterDuration-22498000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentQuarterDuration-6478000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSPrior1QuarterDuration-16000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSCurrentQuarterDuration-21000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that will not be reclassified to profit or loss oci IFRSPrior1QuarterDuration-727000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that will not be reclassified to profit or loss oci IFRSCurrentQuarterDuration-37000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSPrior1QuarterDuration-23241000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSCurrentQuarterDuration-6536000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSPrior1QuarterDuration-1217000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSCurrentQuarterDuration1837000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1QuarterDuration-1735000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSCurrentQuarterDuration26607000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSPrior1QuarterDuration352000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSCurrentQuarterDuration13112000000JPY
Total of items that may be reclassified to profit or loss oci IFRSPrior1QuarterDuration-2600000000JPY
Total of items that may be reclassified to profit or loss oci IFRSCurrentQuarterDuration41556000000JPY
Other comprehensive income IFRSPrior1QuarterDuration-25841000000JPY
Other comprehensive income IFRSCurrentQuarterDuration35020000000JPY
Comprehensive income IFRSPrior1QuarterDuration43085000000JPY
Comprehensive income IFRSCurrentQuarterDuration22974000000JPY
Comprehensive income attributable to owners of parent IFRSPrior1QuarterDuration36444000000JPY
Comprehensive income attributable to owners of parent IFRSCurrentQuarterDuration35697000000JPY
Comprehensive income attributable to non controlling interests IFRSPrior1QuarterDuration6641000000JPY
Comprehensive income attributable to non controlling interests IFRSCurrentQuarterDuration-12723000000JPY
Comprehensive income IFRSPrior1QuarterDuration43085000000JPY
Comprehensive income IFRSCurrentQuarterDuration22974000000JPY
Equity IFRSPrior2YearInstant_ShareCapitalIFRSMember89699000000JPY
Equity IFRSPrior2YearInstant_CapitalSurplusIFRSMember26882000000JPY
Equity IFRSPrior2YearInstant_RetainedEarningsIFRSMember854538000000JPY
Equity IFRSPrior2YearInstant_TreasurySharesIFRSMember-8334000000JPY
Equity IFRSPrior2YearInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember90590000000JPY
Equity IFRSPrior2YearInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember88884000000JPY
Profit loss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_RetainedEarningsIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-19886000000JPY
Other comprehensive income IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember173000000JPY
Comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_RetainedEarningsIFRSMember88884000000JPY
Comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-19886000000JPY
Comprehensive income IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember173000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass